Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $90

Benzinga Newsdesk www.benzinga.com Negative 55.6%

Neg 55.6% Neu 0% Pos 0%

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $101 to $90.